Previous Close | 3.7000 |
Open | 3.6900 |
Bid | 3.8100 x 400 |
Ask | 3.8600 x 400 |
Day's Range | 3.6200 - 3.8700 |
52 Week Range | 2.3600 - 7.2230 |
Volume | |
Avg. Volume | 213,326 |
Market Cap | 115.567M |
Beta (5Y Monthly) | 0.19 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.2800 |
Earnings Date | May 09, 2024 - May 13, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10.88 |
Relmada Therapeutics, Inc. (NASDAQ:RLMD) Q4 2023 Earnings Call Transcript March 19, 2024 Relmada Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.84, expectations were $-0.88. RLMD isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and gentlemen, and […]
Q4 2023 Relmada Therapeutics Inc Earnings Call
Progress in CNS Treatments Amid Financial Challenges